1-20 of 167
B Cohen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, W. Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L. Jaye, Andrew L. Feldman
Journal: Blood
Blood (2024) 144 (19): 2063–2066.
https://doi.org/10.1182/blood.2024025681
Published: 2024
Includes: Supplemental data
Journal Articles

Is rituximab retro in mantle cell lymphoma?

Clinical Trials & Observations
Christine E. Ryan, Jonathon B. Cohen
Journal: Blood
Blood (2024) 144 (3): 241–243.
https://doi.org/10.1182/blood.2024024711
Published: 2024
Journal Articles

Comparing Clinical Characteristics and Outcomes of MYC and BCL6 Double Hit Lymphoma (DHL- BCL6 ) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus Classifications

Arushi Khurana, Raphael Mwangi, James R. Cerhan, Jonathon B. Cohen, Jennifer R. Chapman-Fredricks, Jonathan W. Friedberg, Christopher R. Flowers, Richard Burack, Izidore S. Lossos, Loretta J. Nastoupil, Andrew L. Feldman, Brad S. Kahl, Peter Martin, Grzegorz S. Nowakowski, Brian K. Link, Timothy J. McDonnell, Giorgio Inghirami, Sergei Syrbu, Kiran R. Vij, Matthew J. Maurer, Thomas M. Habermann, Rebecca L. King
Journal: Blood
Blood (2023) 142 (Supplement 1): 67.
https://doi.org/10.1182/blood-2023-190316
Published: 2023
Journal Articles

Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy

Yucai Wang, Melissa C. Larson, Steven R. Hwang, Anita Kumar, Ashlee Joseph, Brian T. Hill, Taylor R. Brooks, David A. Bond, Kami J. Maddocks, Alexey Danilov, Christine McCarthy, Jia Ruan, Imran A. Nizamuddin, Brad S. Kahl, Natalie S. Grover, Nazneen B. Khan, Evguenia Ouchveridze, Aung M. Tun, Philip Young, Craig A. Portell, Zoey I. Harris, Javier L. Munoz, Patrick M. Reagan, Georgio Pongas, Izidore S. Lossos, Christine E. Ryan, Reid W. Merryman, Firas Baidoun, Muhamad Alhaj Moustafa, Drew Gerber, Sabarish R. Ayyappan, Brian K. Link, Arash Velayati, Irl Brian Greenwell, Lauren G Banaszak, Priyanka A Pophali, Anthony C. Stack, Marcus R. Messmer, Mayur Narkhede, Amitkumar N. Mehta, Preetesh Jain, Michael L. Wang, Tamara K. Moyo, Nilanjan Ghosh, Rahul S. Bhansali, Stefan K. Barta, Manali K. Kamdar, Jacob Anna, Alexander V. Stanisic, Reem Karmali, Laveniya Kugathasan, Diego Villa, Matthew J. Maurer, James R. Cerhan, Jonathon B. Cohen, Peter Martin
Journal: Blood
Blood (2023) 142 (Supplement 1): 300.
https://doi.org/10.1182/blood-2023-182942
Published: 2023
Journal Articles

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

Mazie Tsang, Brie N. Noble, Côme Bommier, Carla Casulo, Carrie Thompson, Allison C. Rosenthal, Dai Chihara, Eric Mou, Urshila Durani, Annalynn M Williams, Michelle Hildebrandt, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Susan L. Slager, Andrew L. Feldman, David L Jaye, Jon Tilburt, J. C. C. Villasboas, Ajay Major, Priyanka A Pophali, Talal Hilal, Yucai Wang, Timothy G. Call, Amber Koehler, Javier L. Munoz, Gita Thanarajasingam, Paul J Hampel, Sameer A. Parikh, Loretta J. Nastoupil, Thomas E. Witzig, Grzegorz S. Nowakowski, Stephen M Ansell, Jonathon B. Cohen, Thomas M. Habermann, Christopher Strouse, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Christopher R. Flowers, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 3761.
https://doi.org/10.1182/blood-2023-188382
Published: 2023
Journal Articles

Use of an Integrated Functional Quantitation of Modulation of Transcriptional Pathways (IFQ) Assay in Untreated Mantle Cell Lymphoma Patients

Drew Gerber, Melanie Lopez-McDonald, Weiyuan Wang, Jean L. Koff, Michael Churnetski, Colin B O'Leary, Jonathon B. Cohen, David A. Frank
Journal: Blood
Blood (2023) 142 (Supplement 1): 6103.
https://doi.org/10.1182/blood-2023-190441
Published: 2023
Journal Articles

Pirtobrutinib in Post-cBTKi CLL/SLL: ~30 Months Follow-up and Subgroup Analysis With/Without Prior BCL2i from the Phase 1/2 BRUIN Study

Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Lindsey E. Roeker, Krish Patel, Toby A. Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S. Tam, John F. Seymour, Benoit Tessoulin, Nirav N. Shah, Chaitra S Ujjani, Bita Fakhri, Catherine C. Coombs, Ian W. Flinn, Manish Patel, Sunita D. Nasta, Jonathon B. Cohen, Alvaro J. Alencar, Chan Y. Cheah, Shuo Ma, Joanna M. Rhodes, Deepa Jagadeesh, Pier Luigi Zinzani, Anders Osterborg, Koji Izutsu, Donald E. Tsai, Paolo Abada, Minna Balbas, Jian Li, Amy S. Ruppert, Wojciech Jurczak, William G. Wierda
Journal: Blood
Blood (2023) 142 (Supplement 1): 325.
https://doi.org/10.1182/blood-2023-185852
Published: 2023
Journal Articles

Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Marginal Zone Lymphoma: Results from Phase 1/2 BRUIN Study

Krish Patel, Julie M. Vose, Sunita D. Nasta, Jennifer R. Brown, Kami J. Maddocks, Jennifer A. Woyach, Nirav N. Shah, Bita Fakhri, Benoit Tessoulin, Shuo Ma, Deepa Jagadeesh, Ewa Lech-Maranda, Catherine C. Coombs, Manish Patel, Joanna M. Rhodes, Chaitra S Ujjani, Marc S. Hoffmann, Chan Y Cheah, Talha Munir, David Lewis, Lydia Scarfo, Toby A. Eyre, Alvaro J. Alencar, Jonathon B. Cohen, Andrew D. Zelenetz, Donald E. Tsai, Mei Li, Faith Bian, Paolo Abada, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 1660.
https://doi.org/10.1182/blood-2023-180048
Published: 2023
Journal Articles

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Carla Casulo, Melissa C. Larson, Christopher R. Flowers, Thomas M. Habermann, Thomas E. Witzig, Yucai Wang, Grzegorz S. Nowakowski, Andrew L. Feldman, Loretta J. Nastoupil, Dai Chihara, Richard Burack, Jonathan R Day, Urshila Durani, Peter Martin, Jonathon B. Cohen, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Brian K. Link, James R. Cerhan, Matthew J. Maurer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2023-186684
Published: 2023
Journal Articles

Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL Real-World Study Cohort

Narendranath Epperla, Jeffrey M. Switchenko, Susan M. Geyer, Veronika Bachanova, Stefan K. Barta, Alexey Danilov, Natalie S. Grover, Reem Karmali, Brian T. Hill, Nilanjan Ghosh, Timothy S. Fenske, Peter Martin, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Eric D. Hsi, Kami J. Maddocks, Kristie A. Blum, Thomas M. Habermann, Matthew J. Maurer, Lawrence David Kaplan, Nancy L. Bartlett, John P. Leonard, Jonathon B. Cohen
Journal: Blood
Blood (2023) 142 (Supplement 1): 380.
https://doi.org/10.1182/blood-2023-189505
Published: 2023
Journal Articles

Exploration of Language As a Barrier to the Assessment and Management of CAR T-Cell Therapy Associated Toxicities

Megan Melody, Narendranath Epperla, Matthew J Cortese, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Jonathon B. Cohen, Geoffrey P. Shouse, Ishan Roy, Stefan K. Barta, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 2407.
https://doi.org/10.1182/blood-2023-183041
Published: 2023
Journal Articles

Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed/Refractory Follicular Lymphoma: Results from the Phase 1/2 BRUIN Study

Nirav N. Shah, Pier Luigi Zinzani, Michael L. Wang, Sunita D. Nasta, Ewa Lech-Maranda, Yoshiaki Ogawa, Bita Fakhri, Bryone Kuss, Kaname Miyashita, Krish Patel, Catherine C. Coombs, Shuo Ma, Manish Patel, Minal A. Barve, Benoit Tessoulin, Anastasios Stathis, Won Seog Kim, Daisuke Ennishi, Daigo Hashimoto, Kensuke Kojima, Andrew D. Zelenetz, Jonathon B. Cohen, Julie M. Vose, Kami J. Maddocks, Talha Munir, Fangfang Sun, Faith Bian, Donald E. Tsai, Paolo Abada, Chan Y. Cheah
Journal: Blood
Blood (2023) 142 (Supplement 1): 3026.
https://doi.org/10.1182/blood-2023-181309
Published: 2023
Journal Articles

Diagnosis to Treatment Interval (DTI) Informs Outcomes across Subtypes of Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Raphael Mwangi, Grzegorz S. Nowakowski, Carla Casulo, Dai Chihara, Jonathon B. Cohen, Brad S. Kahl, Izidore S. Lossos, Peter Martin, Yucai Wang, Timothy J. McDonnell, Andrew L. Feldman, David L Jaye, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 3123.
https://doi.org/10.1182/blood-2023-174715
Published: 2023
Journal Articles

Immune Reconstitution and Infection Patterns Following CAR T-Cell Therapy in Patients with Aggressive Lymphoma

Megan Melody, Narendranath Epperla, Geoffrey P. Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Ishan Roy, Stefan K. Barta, Matthew J Cortese, Pallawi Torka, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 1738.
https://doi.org/10.1182/blood-2023-183011
Published: 2023
Journal Articles

Clinical Characteristics, Treatment Trends, and Outcomes of Patients with HHV-8-Negative/Idiopathic Multicentric Castleman Disease Treated with Siltuximab in a Machine Learning-Selected Real-World Cohort

Aaron B Cohen, Melissa Estevez, Jonathan G Kelly, James N Gippetti, Erin L Fidyk, Joshua D. Brandstadter, David C. Fajgenbaum
Journal: Blood
Blood (2023) 142 (Supplement 1): 907.
https://doi.org/10.1182/blood-2023-174924
Published: 2023
Journal Articles

Ilyad: A Phase III Double Blind, Randomized Trial Evaluating Vitamin D (Cholecalciferol) in Patients with Low Tumor-Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab Therapy

Jonathan W. Friedberg, Michael T. Brady, Strawderman Myla, Brad S. Kahl, Izidore S. Lossos, Jonathon B. Cohen, Patrick M. Reagan, Carla Casulo, Barbara L. Averill, Brian K. Link, Paul M. Barr, John P. Leonard, John M. Ashton, Derick R Peterson, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 606.
https://doi.org/10.1182/blood-2023-178088
Published: 2023
Journal Articles

Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Patients with Prior cBTKi: Safety and Efficacy Including High-Risk Subgroup Analyses from the Phase 1/2 BRUIN Study

Jonathon B. Cohen, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Chan Y. Cheah, Toby A. Eyre, Chaitra S Ujjani, Youngil Koh, Won Seog Kim, Sunita D. Nasta, Ian W. Flinn, Benoit Tessoulin, Shuo Ma, Alvaro J. Alencar, David Lewis, Jennifer A. Woyach, Kami J. Maddocks, Krish Patel, Yucai Wang, Joanna M. Rhodes, Constantine S. Tam, John F. Seymour, Hirokazu Nagai, Julie M. Vose, Bita Fakhri, Marc S. Hoffmann, Francisco J. Hernandez-Ilizaliturri, Andrew D. Zelenetz, Anita Kumar, Talha Munir, Donald E. Tsai, Minna Balbas, Bin Liu, Amy S. Ruppert, Bastien Nguyen, Lindsey E. Roeker, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 981.
https://doi.org/10.1182/blood-2023-181627
Published: 2023
Journal Articles

An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma

Yucai Wang, Melissa C. Larson, Umar Farooq, Sara Ekberg, Karin Ekstroem Smedby, Mikkel Runason Simonsen, Carsten Utoft Niemann, Eric J. Zhao, Alina S. Gerrie, Jeffrey M. Switchenko, David A. Bond, Veronika Bachanova, Stefan K. Barta, Brian T. Hill, Peter Martin, Alexey Danilov, Natalie S. Grover, Reem Karmali, Nilanjan Ghosh, Timothy S. Fenske, Brad S. Kahl, Alexandra Albertsson-Lindblad, Ingrid Cecilia Glimelius, Ahmed Ludvigsen Al-Mashhadi, Thomas Stauffer Larsen, Kami J. Maddocks, Brian K. Link, Jonas Paludo, Grzegorz S. Nowakowski, Thomas M. Habermann, Matthew J. Maurer, Diego Villa, Jonathon B. Cohen, Tarec Christoffer Christoffer El-Galaly, Mats Jerkeman, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1656.
https://doi.org/10.1182/blood-2023-182747
Published: 2023
Journal Articles

Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

Côme Bommier, Mazie Tsang, Brie N. Noble, Carrie Thompson, Carla Casulo, Michelle Hildebrandt, Allison C. Rosenthal, Eric Mou, Urshila Durani, Annalynn M Williams, Kathleen Yost, Melissa C. Larson, Brianna Gysbers, Matthew J. Maurer, Andrew L. Feldman, David L Jaye, Peter Martin, Jonathon B. Cohen, Dai Chihara, Izidore S. Lossos, Christopher Strouse, Brad S. Kahl, Thomas M. Habermann, Christopher R. Flowers, Amylou Constance Dueck, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2395.
https://doi.org/10.1182/blood-2023-187056
Published: 2023
Journal Articles

Patterns of Care and Impact of Initial Treatment in Peripheral T-Cell Lymphoma: Outcome Analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study

Jia Ruan, Zhengming Chen, Melissa C. Larson, N. Nora Bennani, Danielle Wallace, Pamela B. Allen, David L Jaye, Jonathon B. Cohen, Luis Enrique Malpica Castillo, Francisco Vega, Giorgio Inghirami, Eric Mou, Carla Casulo, Neha Mehta-Shah, Peter Martin, Matthew J. Maurer, Brad S. Kahl, Izidore S. Lossos, James R. Cerhan, Christopher R. Flowers, Andrew L. Feldman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3079.
https://doi.org/10.1182/blood-2023-180318
Published: 2023